Biography
Carin A. Uyl-de Groot studied Health Care Policy and Management at the Erasmus University Rotterdam. From March 1990 onwards she is working at the institute for Medical Technology Assessment/Department of Health Care Policy and Management at the Erasmus Medical Centre Rotterdam. Her research activities are mainly focused on cost-effectiveness analyses of cancer treatments. Quality of life studies are an integral part of these studies. From 1994 she is program leader of cancer studies. Her main interest consists of diagnostics and therapeutic technologies, economic studies linked to clinical studies, modelling studies, cost studies, quality of life studies, methodological issues and implementation studies particularly in the cancer field. She got her PhD in 1995. Since March 2000 she is director of the institute for Medical Technology Assessment. Since November 2005 she has been appointed professor of health technology assessment at the VU University Medical Center in Amsterdam.
Researcher
Erasmus School of Health Policy & Management
Full professor | Health Technology Assessment (HTA)
- uyl@eshpm.eur.nl
More information
Work
- Elise R.A. Pennings, Anne M. Spanjaart, Frederick W. Thielen, Simone Oerlemans, Anna Fleischer, Carmen Sanges, Maria Gomes Da Silva, Yolanda Cabrerizo, Pacôme Lecot, Lutgart Roux-Opstaele, Caroline Dreuillet, Eglys Gonzalez-Marcano, Olga Millán, Ulrich Jaeger, Julio Delgado, Maik Luu, Barbara Huber, Margot Lorrain, Mariana Pina, Andreas Kremer, Natacha Bolaños, Solène Clavreul, Samantha Nier, Roberto D.K. Liu, Birgit I. Lissenberg-Witte, Sébastien Anguille, Marie Robin, Emma C. Morris, Anna Sureda, Marie Préau, Myriam Pannard, Geertruida H. De Bock, Scott S. Wagers, Hélène Negre, Delphine Maucort-Boulch, Michael Hudecek, Carin A. Uyl-de Groot & Marie José Kersten (2025) - Patient-reported outcomes in patients with hematologic malignancies treated with CAR T-cell therapy in Europe - Blood Advances, 9 (24), 6380-6393 - doi: 10.1182/bloodadvances.2025017081 - [link]
- Delphine Ammar, Carmen Sanges, David Henderson, Inga Schapitz, Michael Hudecek, Maik Luu, Martina Schüssler-Lenz, Christian Buchholz, Paul Franz, Kristin Reiche, Ulrike Köhl, Norbert Ifrah, Bruno Quesnel, Maria Thermeli, Marie Jose Kersten, Franco Locatelli, Maria Luisa D'Amore, Chiara Bonini, Monica Casucci, Ulrike Philippar, Robin Doeswijk, Frederick Thielen, Carin Uyl - de Groot, Judith Theelen, Bernd Schröder, Andreas Kremer, Maria Quaranta, Felipe Prosper, Jan Van den Brulle, Ulf Grawunder, Emmanuel Donnadieu, Anne GALY, Christophe Ferrand, Nina Worel, Dirk Busch, Javier Briones, Leopold Sellner, Jurgen Kuball, Anna Sureda & Jacquelyn Awigena-Cook (2025) - Call for preserving specialized knowledge and contributions of the CAT to advancing ATMPs in Europe - Cytotherapy - doi: 10.1016/j.jcyt.2025.09.007 - [link]
- Nicolas Xander, Tom Belleman, Maximilian Salcher-Konrad, Anne Hendrickx, Jeffrey Chen, Anne-Sophie Klein Gebbink, Peter Schneider, Kate Morgan, Oliver Groene, Isabelle Durand-Zaleski, Frederick Thielen & Carin Uyl-de Groot (2025) - Price determinants and pricing policies concerning potentially innovative health technologies: a scoping review - The European Journal of Health Economics - doi: 10.1007/s10198-025-01834-y - [link]
- Yi Hsuan Chen, Michiel Kroesen, Mischa S. Hoogeman, Matthijs M. Versteegh, Carin A. Uyl-de Groot & Hedwig M. Blommestein (2025) - Reply to comment on Treatment-related toxicity, utility and patient-reported outcomes of head and neck cancer patients treated with proton therapy: A longitudinal study - Clinical and Translational Radiation Oncology, 54 - doi: 10.1016/j.ctro.2025.101013 - [link]
- Saskia P.M. Truijen, Pauline A.J. Vissers, Grard A.P. Nieuwenhuijzen, Maurice J.C. Van Der Sangen, Peter D. Siersema, Marije Slingerland, Nadia H. Mohammad, Laurens V. Beerepoot, Mark I. Van Berge Henegouwen, Pieter C. Van Der Sluis, Camiel Rosman, Ewout A. Kouwenhoven, Hüseyin Aktaş, Hanneke W.M. Van Laarhoven, Carin A. Uyl-De Groot & Rob H.A. Verhoeven (2025) - A cost-effectiveness analysis of the effect of hospital variation in the probability of providing treatment with curative intent in potentially curable esophageal and gastric cancer patients - Diseases of the Esophagus, 38 (4) - doi: 10.1093/dote/doaf057 - [link]
- Tobias B. Polak, Jeremy A. Labrecque, Carin A. Uyl-de Groot & Joost van Rosmalen (2025) - Augmenting Treatment Arms With External Data Through Propensity-Score Weighted Power Priors: An Application in Expanded Access - Statistics in Medicine, 44 (18-19) - doi: 10.1002/sim.70168 - [link]
- Jessica Del Castillo Alferez, Alette Kooiker, Floris P.J. van Alphen, , Carmen van der Zwaan, Herm Jan Brinkman, Joost C.M. Meijers, Alexander B. Meijer, Maartje van den Biggelaar, Tirsa T. van Duijl, Emile van den Akker, Wala Al Arashi, Ryanne Arisz, Lieke Baas, Ruben Bierings, Maartje van den Biggelaar, Johan Boender, Anske van der Bom, Mettine Bos, Martijn Brands, Annelien Bredenoord, Laura Bukkems, Lex Burdorf, Jessica Del Castillo Alferez, Michael Cloesmeijer, Marjon Cnossen, Mariëtte Driessens, Jeroen Eikenboom, Tine Goedhart, Jan Hazelzet, Elise Huisman, Nathalie Jansen, Marieke Kruip, Sebastiaan Laan, Frank Leebeek, Nikki van Leeuwen, Hester Lingsma, Moniek de Maat, Ron Mathôt, Karina Meijer, Iris van Moort, Caroline Mussert, Suzanne Polinder, Diaz Prameyllawati, Simone Reitsma, Lorenzo Romano, Saskia Schols, Carin Uyl, Huan Zhang & Minka Zivkovic (2025) - Proteolytic signatures of coagulation identified by plasma peptidomics - Journal of Thrombosis and Haemostasis, 23 (8), 2494-2507 - doi: 10.1016/j.jtha.2025.04.017 - [link]
- Katharina Brück, Vera Atema, , Annemarie M. Leliveld, Martine Franckena, Richard P. Meijer, Michiel S. van der Heijden, A. Rogier Donders, J. Alfred Witjes, Carin A. Uyl-de Groot, Lisa M.C. van Hoogstraten, Lambertus A. Kiemeney, Joost L. Boormans, Katja K.H. Aben & Maarten C.C.M. Hulshof (2025) - Health-Related Quality of Life in Patients Treated for Nonmetastatic Muscle-Invasive Bladder Cancer: Radical Cystectomy Versus Bladder-Preserving Therapy - International Journal of Radiation Oncology Biology Physics, 123 (4), 1004-1017 - doi: 10.1016/j.ijrobp.2025.06.3866 - [link]
- Pieter Bakx, Carlos Godoy, Saeed Al-Azazi, Amitava Banerjee, Nitzan Burrack, David Ehlig, Christina Fu, Laura A. Hatfield, Asa R. Hartman, Nicole Huang, Dennis T. Ko, Lisa M. Lix, Dominik Moser, Victor Novack, Laura Pasea, Feng Qiu, Kieran L. Quinn, Bheeshma Ravi, Therese A. Stukel, Carin A. Uyl-de Groot, Bruce E. Landon & Peter Cram (2025) - Regionalization of Hip Fracture Care in Five High-Income Countries - Health Services Research, 60 (6) - doi: 10.1111/1475-6773.70002 - [link]
- Milanne Maria Johanna Galekop, Philip C. Calder, Ella J. Baker, Joanna Góralska, Urszula Raźny, Malgorzata Malczewska-Malec, Carin A. Uyl-de Groot & William Ken Redekop (2025) - Cost-Effectiveness of Personalised Nutrition in Adults With Overweight and Obesity: PREVENTOMICS Studies in Poland and the UK - Journal of Human Nutrition and Dietetics, 38 (3) - doi: 10.1111/jhn.70071 - [link]
- Carin Uyl - de Groot, Ken Redekop, Amir Ansaripour, K. Zendehdel, N. Tadayon & F. Sadeghi (2016) - Use of data-mining to perform a real world cost analysis of HER2-positive breast cancer in Iran
Cie Beoordeling Oncologische Middelen
- Start date approval
- July 2025
- End date approval
- July 2028
- Place
- UTRECHT
Gezondheidsraad
- Start date approval
- July 2025
- End date approval
- July 2028
- Place
- DEN HAAG
bestuurslid CPO, Erasmus Medisch Centrum
- Start date approval
- July 2025
- End date approval
- July 2028
- Place
- ONBEKEND
Master Thesis HE
- Year Level
- master, master
- Year
- 2025
- Course Code
- GW4592M
Master Thesis HEPL
- Level
- master
- Year Level
- master
- Year
- 2025
- Course Code
- GW4555M
